The use of antimalarial drugs.
D000328:Adult; D000353:Africa, Southern; D000962:Antimalarials / Q000145:classification / Q000494:pharmacology / Q000627:therapeutic use*; D004352:Drug Resistance, Microbial; D005493:Folic Acid Antagonists; D006801:Humans; D008288:Malaria / Q000517:prevention & control; D010961:Plasmodium / Q000187:drug effects / Q000254:growth & development; D010963:Plasmodium falciparum / Q000187:drug effects; D011803:Quinine / Q000494:pharmacology; D011804:Quinolines / Q000494:pharmacology; D013019:South Africa; D013449:Sulfonamides / Q000494:pharmacology; D013450:Sulfones / Q000494:pharmacology
D000962:Antimalarials; D005493:Folic Acid Antagonists; D011804:Quinolines; D013449:Sulfonamides; D013450:Sulfones; D011803:Quinine